NASDAQ:SPNE - SeaSpine Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $37.80
  • Forecasted Upside: 213.95 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$12.04
▼ -0.28 (-2.27%)

This chart shows the closing price for SPNE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New SeaSpine Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SPNE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SPNE

Analyst Price Target is $37.80
▲ +213.95% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for SeaSpine in the last 3 months. The average price target is $37.80, with a high forecast of $100.00 and a low forecast of $20.00. The average price target represents a 213.95% upside from the last price of $12.04.

This chart shows the closing price for SPNE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 5 polled investment analysts is to buy stock in SeaSpine. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/24/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/24/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/23/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/21/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/20/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/19/2022

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/21/2021Truist FinancialLower Price TargetBuy$25.00 ➝ $20.00High
10/28/2021Loop CapitalInitiated CoverageBuy$100.00High
9/27/2021BTIG ResearchLower Price TargetBuy$28.00 ➝ $23.00High
4/14/2021Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$24.00High
4/8/2021Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$19.00 ➝ $24.00High
4/6/2021BTIG ResearchBoost Price TargetBuy$25.00 ➝ $28.00High
1/29/2021Piper SandlerBoost Price TargetOverweight$18.00 ➝ $22.00Low
10/19/2020Stifel NicolausInitiated CoverageBuy$22.00Medium
8/4/2020BTIG ResearchReiterated RatingBuy$16.00High
6/15/2020Cantor FitzgeraldInitiated CoverageBuy$18.00Low
6/8/2020Cantor FitzgeraldReiterated RatingOverweightHigh
4/19/2020Wells Fargo & CompanyUpgradeUnderweight ➝ Equal WeightLow
4/7/2020Wells Fargo & CompanyUpgradeUnderweight ➝ Equal Weight$10.00High
4/2/2020SunTrust BanksInitiated CoverageBuy$15.00Medium
12/12/2019Wells Fargo & CompanyDowngradeOverweight ➝ Underweight$13.00High
8/4/2019BTIG ResearchReiterated RatingBuy$20.00High
5/2/2019Cantor FitzgeraldReiterated RatingBuy$22.00Medium
3/31/2019BTIG ResearchReiterated RatingBuy$20.00Medium
1/7/2019Cantor FitzgeraldReiterated RatingBuy$22.00Medium
12/13/2018Wells Fargo & CompanyInitiated CoverageOutperform$22.00Medium
11/8/2018HC WainwrightSet Price TargetBuy$19.00Medium
10/4/2018Cantor FitzgeraldReiterated RatingOverweight$22.00Medium
10/3/2018LADENBURG THALM/SH SHSet Price TargetBuy$23.00Medium
10/2/2018Piper Jaffray CompaniesBoost Price TargetOverweight$16.00 ➝ $20.00High
7/31/2018HC WainwrightReiterated RatingBuy$15.00High
7/30/2018Cantor FitzgeraldReiterated RatingBuy$16.00High
7/16/2018HC WainwrightReiterated RatingBuyLow
5/31/2018Cantor FitzgeraldInitiated CoverageOverweight$16.00Low
5/4/2018HC WainwrightSet Price TargetBuy$15.00Low
3/2/2018BTIG ResearchReiterated RatingBuy$17.00Low
3/2/2018HC WainwrightSet Price TargetBuy$15.00High
12/14/2017LADENBURG THALM/SH SHInitiated CoverageBuy$20.00Low
11/6/2017BTIG ResearchReiterated RatingBuyN/A
11/3/2017HC WainwrightReiterated RatingBuy$15.00N/A
8/20/2017Piper Jaffray CompaniesReiterated RatingBuy$22.00Low
8/7/2017HC WainwrightSet Price TargetBuy$15.00Low
7/10/2017HC WainwrightInitiated CoverageBuy ➝ Buy$15.00Medium
6/20/2017BTIG ResearchInitiated CoverageBuyHigh
(Data available from 1/19/2017 forward)

News Sentiment Rating

0.46 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/23/2021
  • 2 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/23/2021
  • 4 very positive mentions
  • 9 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
8/22/2021
  • 2 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/21/2021
  • 6 very positive mentions
  • 14 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/21/2021
  • 2 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
11/20/2021
  • 2 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
12/20/2021
  • 5 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
1/19/2022

Current Sentiment

  • 5 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
SeaSpine logo
SeaSpine Holdings Corp. operates as a medical technology company. The firm engages in the design, developmen and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. It products include thoracolumbar hardware, cervical hardware, orthobiologics, and spine pure strip. The company was founded on February 12, 2015 and is headquartered in Carlsbad, CA.
Read More

Today's Range

Now: $12.04
Low: $11.92
High: $12.36

50 Day Range

MA: $13.47
Low: $12.04
High: $15.36

52 Week Range

Now: $12.04
Low: $11.86
High: $22.97

Volume

68,640 shs

Average Volume

103,362 shs

Market Capitalization

$438.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.17

Frequently Asked Questions

What sell-side analysts currently cover shares of SeaSpine?

The following sell-side analysts have issued research reports on SeaSpine in the last year: BTIG Research, Loop Capital, Piper Sandler, TheStreet, Truist Financial Co., Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for SPNE.

What is the current price target for SeaSpine?

5 Wall Street analysts have set twelve-month price targets for SeaSpine in the last year. Their average twelve-month price target is $37.80, suggesting a possible upside of 214.0%. Loop Capital has the highest price target set, predicting SPNE will reach $100.00 in the next twelve months. Truist Financial Co. has the lowest price target set, forecasting a price of $20.00 for SeaSpine in the next year.
View the latest price targets for SPNE.

What is the current consensus analyst rating for SeaSpine?

SeaSpine currently has 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SPNE will outperform the market and that investors should add to their positions of SeaSpine.
View the latest ratings for SPNE.

How do I contact SeaSpine's investor relations team?

SeaSpine's physical mailing address is 5770 ARMADA DRIVE, CARLSBAD CA, 92008. The medical equipment provider's listed phone number is (760) 727-8399 and its investor relations email address is [email protected] The official website for SeaSpine is www.seaspine.com.